HIV Rapid Testing

Posted in: HIV Rapid Testing


HIV rapid tests are short incubation immunoassays used for screening and produce results in twenty minutes or less.  HIV rapid tests mostly use blood or oral fluid.  Blood specimens are collected typically via fingerprick, venepuncture can also be used, or oral fluid is collected by swab from the gum line. It is not a diagnostic test; all reactive results need to be confirmed by reference testing.  They are also known as HIV point of care tests (PoCT).


In December 2012, the Therapeutic Goods Administration (TGA) approved the first HIV rapid test for use at the point of care in Australia.  The Alere Determine™ HIV Combo test is now registered for use as a screening test. The TGA has placed a number of strict conditions around the use of the device, aiming to ensure the product is only available for use by testing sites and health professionals who are able to deliver testing in a safe and appropriate manner.

ASHM believes HIV rapid HIV testing has an important role to play in Australia's National HIV Strategy. As a signatory to the Melbourne Declaration, ASHM has been working to support the implementation of HIV PoCT, as per the conditions set out both by the TGA and the National HIV Testing Policy.

For information about implementing HIV rapid testing at your service please contact contact Kate Bath, HIV Program Manager, National Policy and Education Division at This email address is being protected from spambots. You need JavaScript enabled to view it. or 0413 471 937.

Please see below for a list of sites by state/territory which are offering HIV rapid testing.  Some sites listed are using the TGA approved test and some sites are part of research trials using other HIV rapid test devices.  Please contact the individual site for more information.


If your site is not listed please contact ASHM.











Development of this site and the 2014 and 2017 revisions of the testing policies was supported by: Australian Government Department of Health and Ageing